I am an ophthalmologist currently working in New Delhi, India. When India experienced the initial impact of COVID-19, I was working in a Government Hospital in New Delhi. One of my colleagues (a young, energetic person with no comorbidities) working in the same department, unfortunately, tested positive for COVID-19 in October 2020. He developed severe pneumonia with a high-grade fever which needed hospitalization for 14 days. He had post-viral myalgia and weakness for another two weeks and then he finally resumed his duties after a gap of one month to serve the people of the country.

References

1. Zeberg H and Pääbo S. “The major genetic risk factor for severe COVID-19 is inherited from Neanderthals”. Nature 587 (2020): 610-612.
2. COVID-19 Host Genetics Initiative. The COVID-19 Host Genetics Initiative, a global initiative to elucidate the role of host genetic factors in susceptibility and severity of the SARS-CoV-2 virus pandemic”. European Journal of Human Genetics 28 (2020): 715-718.
3. Knoll MD and Wonodi C. “Oxford-AstraZeneca COVID-19 vaccine efficacy”. Lancet 397 (2021): 72-74.

Citation

Citation: Sunita and Faizan Mehmood. “COVID-19 is Not Over Yet - A Personal Experience!".Acta Scientific Ophthalmology 4.11 (2021): .

Copyright

Copyright: © 2021 Sunita and Faizan Mehmood. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.